New drug trial offers hope for painful mouth condition
NCT ID NCT06158113
Summary
This study is testing if the drug baricitinib can help control moderate to severe oral lichen planus, a chronic inflammatory condition that causes painful sores in the mouth. It involves 10 adults who have not improved with other treatments. Participants will take the drug for six months while researchers measure changes in their mouth sores and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL LICHEN PLANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UNC Dermatology and Skin Cancer Center
Chapel Hill, North Carolina, 27516, United States
Conditions
Explore the condition pages connected to this study.